2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)
Clinical trial NCT04941599 · RECRUITING
Trial details
- NCT number
- NCT04941599
- Sponsor
- Vanderbilt University Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-14
- Primary completion
- 2027-06-30
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.